Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH)—a rare, aggressive ...

A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" by Rackear et al. was published in Oncotarget's Volume 15 on November 22, ...

A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" ...

was published in Oncotarget's Volume 15 on November 22, 2024, titled " Advancements in cell-penetrating monoclonal antibody treatment. " This new publication by Sai Pallavi Pradeep and Raman Bahal ...

The WVU Rockefeller Neuroscience Institute is providing patients greater statewide and regional access to a groundbreaking ...

Hans Lee, MD, MD Anderson Cancer Center, talks about recent advancements in multiple myeloma treatment pathways.

Gene therapy for haemophilia A using Roctavian and lentivirus vector shows promise in treating the rare, hereditary condition ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Three monoclonal antibodies (cetuximab, bevacizumab and panitumumab) have been approved for the treatment of colorectal cancer in the USA and a large number of other monoclonal antibodies are ...

Notably, more than half of the observed responses were substantially stronger than those achieved under the initial anti-PD-(L)1 treatment, indicating that GDF-15-targeted antibodies can not only ...